<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2024-17-3-96-101</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1556</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FOR OPHTHALMOLOGY PRACTITIONERS</subject></subj-group></article-categories><title-group><article-title>Клинический случай васкулита зрительного нерва на фоне перенесенного мононуклеоза</article-title><trans-title-group xml:lang="en"><trans-title>Optic disc vasculitis secondary to mononucleosis: a case report</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ворошилова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Voroshilova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ворошилова Наталья Александровна — канд. мед. наук, врач-офтальмолог.</p><p>ул. Рублевское предместье, д. 2, корп. 2, д. Глухово, г. о. Красногорск, Московская область, 143421</p></bio><bio xml:lang="en"><p>Natalya A. Voroshilova — Cand. Med. Sci., ophthalmologist.</p><p>2 Bldg. 2, Rublevskoe Predmestye St., Glukhovo village, Krasnogorsk, Moscow region, 143421</p></bio><email xlink:type="simple">nav108@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукина</surname><given-names>М. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukina</surname><given-names>M. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лукина Марина Константиновна — студентка 6-го курса педиатрического факультета.</p><p>ул. Трубецкая, д. 8, стр. 2, Москва, ГСП-1, 119991</p></bio><bio xml:lang="en"><p>Marina K. Lukina — 6th year student of pediatric faculty.</p><p>8, Bldg.2, Trubetskaya St., Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>АО «Ильинская больница»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Il'inskaya hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>02</day><month>10</month><year>2024</year></pub-date><volume>17</volume><issue>3</issue><fpage>96</fpage><lpage>101</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ворошилова Н.А., Лукина М.К., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Ворошилова Н.А., Лукина М.К.</copyright-holder><copyright-holder xml:lang="en">Voroshilova N.A., Lukina M.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1556">https://roj.igb.ru/jour/article/view/1556</self-uri><abstract><p>Васкулиты сетчатки и зрительного нерва являются одним из сложных, редких и интересных вопросов в клинической офтальмологии. Отсутствие достаточного опыта у практикующих врачей, разнообразие клинических проявлений и течения, ограниченность технических возможностей для полноценной диагностики и наблюдения, в частности флюоресцентной ангиографии, делает сложным ведение таких пациентов. Представленный клинический случай иллюстрирует васкулит зрительного нерва у молодой пациентки. Мы предполагаем, что перенесенный инфекционный мононуклеоз привел к дисфункции иммунитета и развитию аутоиммунного васкулита зрительного нерва. На фоне назначенной иммуносупрессивной терапии удалось добиться ремиссии и получить хороший клинический результат.</p></abstract><trans-abstract xml:lang="en"><p>Vasculitis of the retina and the optic nerve is one of the most complex, rare and challenging issues in clinical ophthalmology. Managing patients with this diagnosis is difficult because practical ophthalmologists lack sufficient experience, clinical manifestations and courses of the disease are versatile and technical means of full-scale diagnostics and observation, including fluorescein angiography are limited. The report illustrates a particular case of optic nerve vasculitis in a young female patient. We assumed that an infectious mononucleosis that she had experienced led to immune dysfunction and the development of autoimmune vasculitis of the optic nerve. An immunosuppressive therapy was prescribed, which allowed achieving a good clinical result.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>клинический случай</kwd><kwd>васкулит сетчатки</kwd><kwd>васкулит зрительного нерва</kwd><kwd>ретиноваскулит</kwd><kwd>инфекционный мононуклеоз</kwd><kwd>вирус Эпштейна — Барр</kwd></kwd-group><kwd-group xml:lang="en"><kwd>case report</kwd><kwd>retinal vasculitis</kwd><kwd>optic nerve vasculitis</kwd><kwd>retinovasculitis</kwd><kwd>infectious mononucleosis</kwd><kwd>Epstein — Barr virus</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Trusko B, Thorne J, Jabs D, et al. The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013; 52 (3): 259–65, S1-6. doi: 10.3414/ME12-01-0063</mixed-citation><mixed-citation xml:lang="en">Trusko B, Thorne J, Jabs D, et al. The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques. Methods Inf Med. 2013; 52 (3): 259–65, S1-6. doi: 10.3414/ME12-01-0063</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Малов И.В., Сеннова Л.Г., Гришина Е.Е., и др. Клинические особенности васкулита зрительного нерва. Практическая медицина. 2017; 9 (110): 125–7.</mixed-citation><mixed-citation xml:lang="en">Malov I.V., Sennova L.G., Grishina E.E., et al. Clinical features of the optic nerve vasculitis. Prakticheskaya meditsina. 2017; 9 (110): 125–7 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Уметалиева М.Н., Усенко В.А. Особенности изменений глазного дна при идиопатических ретиноваскулитах. Здравоохранение Кыргызстана. Бишкек. 2019; 4: 15–9.</mixed-citation><mixed-citation xml:lang="en">Umetalieva M.N., Usenko V.A. Features of changes of the fundus during idiopathic retinovasculitis. Zdravookhranenie Kyrgyzstana. 2019; 4: 15–9 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Charles H. Retinal vasculitis. In: Duane's Ophthalmology on CD-ROM. Tasman and Jaeger, eds. 1998; 4; Chapter 47.</mixed-citation><mixed-citation xml:lang="en">Charles H. Retinal vasculitis. In: Duane's Ophthalmology on CD-ROM. Tasman and Jaeger, eds. 1998; 4; Chapter 47.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Agrawal R, Gunasekeran DV, Gonzalez-Lopez JJ, et al. Peripheral retinal vasculitis: Analysis of 110 consecutive cases and a contemporary reappraisal of tubercular etiology. Retina. 2017 Jan; 37 (1): 112–7. doi: 10.1097/IAE.0000000000001239</mixed-citation><mixed-citation xml:lang="en">Agrawal R, Gunasekeran DV, Gonzalez-Lopez JJ, et al. Peripheral retinal vasculitis: Analysis of 110 consecutive cases and a contemporary reappraisal of tubercular etiology. Retina. 2017 Jan; 37 (1): 112–7. doi: 10.1097/IAE.0000000000001239</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal A, Rubsam A, Zur Bonsen L, et al. A comprehensive update on retinal vasculitis: etiologies manifestations and treatments. J Clin Med. 2022; 11 (9): 2525. https:// doi. org/ 10. 3390/ jcm11 092525</mixed-citation><mixed-citation xml:lang="en">Agarwal A, Rubsam A, Zur Bonsen L, et al. A comprehensive update on retinal vasculitis: etiologies manifestations and treatments. J Clin Med. 2022; 11 (9): 2525. https:// doi. org/ 10. 3390/ jcm11 092525</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016 May; 28 (3): 228–35. doi: 10.1097/BOR.0000000000000271</mixed-citation><mixed-citation xml:lang="en">Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016 May; 28 (3): 228–35. doi: 10.1097/BOR.0000000000000271</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mir TA, Reddy AK, Burkholder BM, et al. Clinical features and incidence rates of ocular complications in patients with retinal vasculitis. Am J Ophthalmol. 2017 Jul; 179: 171–8. doi: 10.1016/j.ajo.2017.05.007</mixed-citation><mixed-citation xml:lang="en">Mir TA, Reddy AK, Burkholder BM, et al. Clinical features and incidence rates of ocular complications in patients with retinal vasculitis. Am J Ophthalmol. 2017 Jul; 179: 171–8. doi: 10.1016/j.ajo.2017.05.007</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Witkin AJ, Hahn P, Murray TG, et al. Occlusive retinal vasculitis following intravitreal Brolucizumab. J Vitreoretin Dis. 2020 Jul; 4 (4): 269–79. doi: 10.1177/2474126420930863</mixed-citation><mixed-citation xml:lang="en">Witkin AJ, Hahn P, Murray TG, et al. Occlusive retinal vasculitis following intravitreal Brolucizumab. J Vitreoretin Dis. 2020 Jul; 4 (4): 269–79. doi: 10.1177/2474126420930863</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения Российской Федерации. Клинические рекомендации «Увеиты неинфекционные». Available at: http://avo-portal.ru/documents/fkr/Klinicheskie_rekomendacii_final_0222.pdf</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the Russian Federation. Clinical guidelines “Non-infectious uveitis” (In Russ.). Available at: http://avo-portal.ru/documents/fkr/Klinicheskie_rekomendacii_final_0222.pdf</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Жазыбаев Р.С., Сорокин Е.Л. Частота, клинические проявления, этиологическая диагностика задних увеитов, сопровождающихся ретиноваскулитами. Современные технологии в офтальмологии. 2022; 6: 82–9. doi:10.25276/2312-4911-2022-6-82-89</mixed-citation><mixed-citation xml:lang="en">Zhazybaev R.S., Sorokin E.L. Frequency, clinical manifestations, etiological diagnosis of posterior uveitis accompanied by retinovasculitis. Sovremennye tekhnologii v oftal'mologii. 2022; 6: 82–9 (In Russ.). doi:10.25276/2312-4911-2022-6-82-89</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Якушина С.А., Кистенева Л.Б. Влияние персистенции вируса Эпштейна — Барр на развитие иммуноопосредованных соматических заболеваний. Российский вестник перинатологии и педиатрии. 2018; 63 (1); 22–7. doi:10.21508/1027-4065-2018-63-1-22-27</mixed-citation><mixed-citation xml:lang="en">Yakushina S.A., Kisteneva L.B. Influence of the Epstein-Barr virus persistence upon the development of the immune-mediated somatic diseases. Rossiyskiy vestnik perinatologii i pediatrii. 2018; 63 (1): 22–7 (In Russ.). doi:10.21508/1027-4065-2018-63-1-22-27</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Keorochana N. A case report of Epstein-Barr virus-associated retinal vasculitis: successful treatment using only acyclovir therapy. International medical case reports journal. 2016; 9: 213–8. doi:10.2147/IMCRJ.S107089</mixed-citation><mixed-citation xml:lang="en">Keorochana N. A case report of Epstein-Barr virus-associated retinal vasculitis: successful treatment using only acyclovir therapy. International medical case reports journal. 2016; 9: 213–8. doi:10.2147/IMCRJ.S107089</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Victor AA, Sukmana N. Retinal vasculitis associated with Epstein-Barr infection, a case report. Retinal cases &amp; brief reports. 2018; 12 (4): 314–7. doi: 10.1097/ICB.0000000000000508</mixed-citation><mixed-citation xml:lang="en">Victor AA, Sukmana N. Retinal vasculitis associated with Epstein-Barr infection, a case report. Retinal cases &amp; brief reports. 2018; 12 (4): 314–7. doi: 10.1097/ICB.0000000000000508</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaguchi M, Yoshioka T, Yamakawa T, et al. Anti-neutrophil cytoplasmic antibody-associated vasculitis associated with infectious mononucleosis due to primary Epstein-Barr virus infection: report of three cases. Clin Kidney J. 2014 Feb; 7 (1): 45–8. doi: 10.1093/ckj/sft140</mixed-citation><mixed-citation xml:lang="en">Yamaguchi M, Yoshioka T, Yamakawa T, et al. Anti-neutrophil cytoplasmic antibody-associated vasculitis associated with infectious mononucleosis due to primary Epstein-Barr virus infection: report of three cases. Clin Kidney J. 2014 Feb; 7 (1): 45–8. doi: 10.1093/ckj/sft140</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dhirachaikulpanich D, Chanthongdee K, Zheng Y, Beare NAV. A systematic review of OCT and OCT angiography in retinal vasculitis. J Ophthalmic Inflamm Infect. 2023 Jan 30; 13 (1): 1. doi: 10.1186/s12348-023-00327-4</mixed-citation><mixed-citation xml:lang="en">Dhirachaikulpanich D, Chanthongdee K, Zheng Y, Beare NAV. A systematic review of OCT and OCT angiography in retinal vasculitis. J Ophthalmic Inflamm Infect. 2023 Jan 30; 13 (1): 1. doi: 10.1186/s12348-023-00327-4</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma P, Sharma S, Baltaro R, Hurley J. Systemic vasculitis. Am Fam Physician. 2011 Mar 1; 83 (5): 556–65. PMID: 21391523</mixed-citation><mixed-citation xml:lang="en">Sharma P, Sharma S, Baltaro R, Hurley J. Systemic vasculitis. Am Fam Physician. 2011 Mar 1; 83 (5): 556–65. PMID: 21391523</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Усенко В.А., Уметалиева М. Н. Комплексный план лечения идиопатических ретиноваскулитов. Бюллетень науки и практики. 2021; 7 (4): 176–85. doi:10.33619/2414-2948/65/21</mixed-citation><mixed-citation xml:lang="en">Usenko V.A., Umetalieva M.N. Comprehensive treatment plan for idiopathic neurovasculitis. Byulleten' nauki i praktiki. 2021; 7 (4): 176–85 (In Russ.). doi:10.33619/2414-2948/65/21</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А. Рекомендации по ведению больных васкулитами (по материалам рекомендаций Европейской антиревматической лиги). Современная ревматология. 2009; 2: 5–9.</mixed-citation><mixed-citation xml:lang="en">Baranov A.A. Recommendations for the management of patients with vasculitis (based on the recommendations of the European Anti-Rheumatic League). Sovremennaya revmatologiya. 2009; 2: 5–9 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Еманова Л.П., Смолякова Г.П., Егоров В.В. и др. Клинико-этиологические особенности изолированных васкулитов диска зрительного нерва. Современные технологии в офтальмологии. 2019; 2: 206–10. doi:10.25276/2312-4911-2019-2-206-210</mixed-citation><mixed-citation xml:lang="en">Emanova L.P., Smoliakova G.P., Egorov V.V., et al. Clinical and etiological features of isolated optic disc vasculitis. Sovremennye tekhnologii v oftal'mologii. 2019; 2: 206–10 (In Russ.). doi:10.25276/2312-4911-2019-2-206-210</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
